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Depression and anxiety disorders are the most common 
mental illnesses, each affecting in excess of 10-15% of the 
population at some time in their lives. Both anxiety and 
depressive disorders are amenable to pharmacological 
treatments that have been developed since the 1950s 
1
. 
Imipramine is tertiary amine tricyclic antidepressive drug. 
It enhances monoaminergic neurotransmission by 




Alprazolam is belonging to the benzodiazepines. It has the 
capacity  to promote the binding of the major inhibitory 
neurotransmitter γ-aminobutyric acid (GABA) to the 
GABAA subtype of GABA receptors, which exist as multi-
subunit, ligand-gated chloride channels, thereby enhancing 






 channels (L-type or slow channels) 
mediate the entry of extracellular Ca
2+
 into smooth muscle 
and cardiac myocytes and sinoatrial (SA) and 
atrioventricular (AV) nodal cells in response to electrical 
depolarization. In both smooth muscle and cardiac 
myocytes, Ca
2+
 is a trigger for contraction, albeit by 
different mechanisms. Ca
2+
 channel antagonists, also 
called Ca
2+
 entry blockers, inhibit Ca
2+
 channel function. 
In vascular smooth muscle, this leads to relaxation, 
especially in arterial beds 
5
. Verapamil is belonging to the 
phenylalkylamine compound. Verapamil enhanced the 
antidepressant action of alprazolam 
6
,  Verapamil as an 
inhibitor of the CYP 450 3A4 may affect the imipramine 




Porsolt et al. 
8
 proposed Despair swim test (DST) as a 
model to test for antidepressant activity of any substances. 
It was suggested that mice or rats forced to swim in a 
restricted space from which they cannot escape are 
induced to a characteristic behavior of immobility. This 
behavior reflects a state of despair which can be reduced 
by several agents, which are therapeutically effective in 
human depression 
9
. The rat DST model has been widely 
used in screening antidepressants because it is simple and 
has been reported to be reliable across laboratories. The rat 
version seems to be more selective (fewer false 
positives).The rat model is more sensitive than the mouse 
model because it produces fewer false negatives 
10
. The 
DST is specific enough to discriminate between 
antidepressants, neuroleptics and anxiolytics 
11
. Behavioral 
despair is mediated by central catecholamines. Drugs that 
increase central transmission of dopamine or NA decrease 
immobility, whereas agents having the opposite effect 
increase immobility. The advantage of the mouse DST 
model is that it can readily test the possible mechanisms of 
antidepressant action by using specific 
agonists/antagonists. By augmenting or blocking 
antidepressant activity with agonist/antagonist receptor 
ligands, it is possible to detect which receptor is involved 
in the antidepressant effect 
12
.  
In this study behavior despair models was used to 
investigate the effect of the calcium channel blockers, 
nifedipine and verapamil, on the antidepressant action of 
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alprazolam and imipramine. These two calcium channel 
blockers are used in the treatment of physical illnesses that 
may be concurrent with depression. Understanding the 
interaction between antidepressants and calcium channel 
blockers could indicate whether there is a need to modify 
antidepressant doses when co-administered with calcium 
channel blockers. 
MATERIALS AND METHODS 
Ethical Consideration: Prior to the initiation of the study, 
necessary permission was obtained from the Institutional 
Animal Ethics Committee. And the maintenance of the 
animals as well all the procedures of the experiment were 
as per the Committee for the Purpose of Control and 
Supervision on Experiments on Animals (CPCSEA) 
guidelines. 
Study duration: The study was conducted during the 
month of January to March 2006, at the Pharmacology 
Department of Burdwan Medical College, West Bengal, 
India.  
Study Design and Methodology:  54 Male Sprague-
Dawley rats weighing 160–180 g are collected from the 
institutional animal house. They were kept in standard 
plastic rat cages and fed with a standard rat food which 
was in pellet form (which was bought from Hindustan 
Animal Feeds) and tap water. The rooms were equipped 
with lighting, conditioning, moisture and heat control.  
Groups of rats were housed in separate cages. The animals 
were housed at room temperature (20–25°C) and a 12-h 
dark/light cycle. The animals were adapted to their new 
surroundings for three days before the initiation of the 
experiment. 
Because alprazolam is not freely soluble in saline, all the 
drugs were dissolved in 1% Tween 80 in distilled water. 
They were injected intraperitoneally. Imipramine was 
given at 12 mg/kg and alprazolam at 6 mg/kg. The doses 
of calcium channel blockers were then selected 
accordingly.  
Rats were divided into nine groups (n = 6 per group). One 
group received a single dose of 6ml/kg of 1% Tween 80; 
two groups each received a single dose of the 
antidepressant alone (alprazolam, 6mg/kg; imipramine, 
12mg/kg); two groups each received a single dose of the 
calcium channel blocker (nifedipine, 7mg/kg; verapamil, 
12mg/kg); four groups each received a single dose of the 
calcium channel blocker followed by a single dose of the 
antidepressant (with same doses used for either in the 
previous four groups). Drug administration was performed 
concurrently on the nine groups. For all groups, the time of 
onset of immobility was measured 60 min after drug 
administration. In this study I had chosen the Despair 
swim test (DST) as proposed by Porsolt et al. 
8
. 
 Rats were individually forced to swim inside a vertical 
Plexiglas cylinder (height: 40 cm; diameter: 18 cm, 
containing 15 cm of water maintained at 25 °C). Rats 
placed in the cylinders for the first time were initially 
highly active, vigorously swimming in circles, trying to 
climb the wall or diving to the bottom. After 2–3 min 
activity began to subside and to be interspersed with 
phases of immobility or floating of increasing length. After 
5–6 min immobility reached a plateau where the rats 
remain immobile for approximately 80% of the time. After 
15 min in the water the rats were removed and allowed to 
dry in a heated enclosure (32 °C) before being returned to 
their home cages. They were again placed in the cylinder 
24 h later and the total duration of immobility was 
measured during a 5 min test. Floating behavior during this 
5 min period had been found to be reproducible in 
different groups of rats. An animal was judged to be 
immobile whenever it remains floating passively in the 
water in a slightly hunched but upright position, its nose 
just above the surface. Test drugs or standard were 
administered one hour prior to testing. 
Statistical analysis: All the collected data were analyzed 
by using the Statistical Package for the Social Science 
(SPSS) ver-16 in Windows-7. If the data were normally 
distributed one way Anova test was applied. And if the 
data were not normally distributed, groups were compared 
using Wilcoxon signed rank test. A value of p< 0.05 was 
considered statistically significant.  
RESULTS AND ANALYSIS  
There was an effect of nifedipine on the onset of 
immobility: Administration of imipramine, alprazolam, or 
nifedipine separately produced a significant delay in the 
onset of immobility compared to the control group. The 
combined administration of alprazolam and nifedipine 
produced a significant delay in the onset of immobility 
compared to either alprazolam treated rats or the control 
group. The effect of imipramine on the onset of immobility 
(delay) was potentiated by the administration of nifedipine 
(Table 1).  
Table 1: Effects of Nifedipine on the onset of immobility by alprazolam and imipramine using the despair swim test 
model of depression. The values are expressed as mean ± SD (a): p ≤ 0.05 compared to control group treated with 
Tween 80- treated. (b): p ≤ 0.05 compared to group treated with alprazolam + nifedipine. (c): p ≤ 0.05 compared to 
group treated with imipramine + nifedipine. 
Treatment ( n= 6)  Table No. 1 Onset of Immobility ( Seconds) 
Tween 80 39.09 ± 0.93 
Alprazolam ( 6 mg/ kg) 52.09 ± 1.09   (a, b) 
Alprazolam (6mg/kg) & Nifedipine( 7mg/kg) 69.15 ± 1.17    (a) 
Imipramine ( 12mg/kg) 79.17 ± 1.08    (a, c) 
Imipramine (12mg/kg)&Nifedipine(7mg/kg)  82.5 ± 1.09     (a) 
Nifedipine ( 7mg/kg)  59.08 ± 1.59   ( a, b, c )  
 
Effects of verapamil on the onset of immobility: 
Administration of verapamil, alprazolam or imipramine 
produced a significant delay in the onset of immobility 
compared to the control group. Co-administration of 
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verapamil augmented the effects of imipramine. Similarly, 
coadministration of verapamil augmented the effects of 
alprazolam. My findings demonstrate that verapamil 
significantly delays the onset of immobility produced by 
alprazolam (Table 2).  
Table 2: Effects of verapamil on the onset of immobility produced by alprazolam or imipramine using the despair 
swim test model of depression. The values are expressed as mean ± SD. (a): p ≤ 0.05 compared to control group 
treated with Tween 80-treated. (b): p ≤ 0.05 compared to group treated with alprazolam + verapamil. (c): p ≤ 0.05 
compared to the group treated with imipramine + verapamil. 
Treatment ( n= 6) Table No.2 Onset of Immobility ( Seconds) 
Tween 80 39.09 ± 0.93 
Alprazolam ( 6mg/kg)  52.09 ± 1.09   (a, b)  
Alprazolam ( 6mg/kg)& Verapamil (12 mg/ kg ) 80.9 ± 0.89     ( a) 
Imipramine ( 12 mg/kg )  79.17 ± 1.08    (a, c)  
Imipramine ( 12 mg/kg )& Verapamil (12 mg/kg)  91.08 ± 1.09    (a) 
Verapamil (12mg/kg)  58.01 ± 0.02    ( a, b, c )  
 
DISCUSSION  
 It has been suggested that calcium channel inhibitors may 
have antidepressant properties, and that calcium may play 
an important role in affective disorders. Voltage-dependent 
calcium channel antagonists have been reported to produce 
antidepressant-like effects in rodents. Interruption of the 
Ca
2+
-calmodulin-NOS-guanylyl cyclase subcellular 
signaling pathway at any point produces antidepressant-
like effects 
13
. In my study, nifedipine delayed the onset of 
immobility in the forced swimming maze. This 
antidepressant action could have been mediated by 5-HT1A 
activation, whereby nifedipine reduced 5-HT uptake. This 
would lead to an increase in the cytosolic calcium activity 
via 5-HT2 receptors 
14
. Serotonin may activate calcium 
influx through calcium channels by activation of 5- HT 
receptors, which are insensitive to nifedipine, in neuronal 
cells. The increase in calcium influx is through 5-HT3 
receptors, the 5- HT3 receptor being a ligand-gated ion 
channel activated by the neurotransmitter serotonin. 
Receptors of this subtype have been localized to several 
regions of the brain; they appear to be involved in many 
neuronal functions, and to mediate antidepressant effects 
15
. In glial cells, the increase in intracellular calcium is 
through 5- HT2 receptors 
14
. It has been suggested that the 
pharmacology of L-type Ca
2+
-channel blockers overlaps 
with that of 5-HT2 receptor antagonists 
15
. Nifedipine may 
produce an antidepressant action through GABAA 
activation, which leads to the release of NA that produces 
an antidepressant effect 
16
. This may be GABA acting on 
second inhibitory interneurons (as in direct and indirect 
pathways of extrapyramidal systems). Nifedipine may also 
produce its antidepressant effect by increasing the release 
of intracellular calcium through GABAA receptors and NA 
16
. The central antidepressant effect of nifedipine may be 
mediated through an interaction, with novel modulatory 




Verapamil showed an anti depressant like effect as it 
delayed the onset of immobility in the swimming maze. 
Studies have shown that verapamil modulates the action of 
antidepressant drugs that down regulate β adrenergic 
systems 
17
. It has a similar final effect as β blockers, and 
shares this effect with antidepressant drugs. Working on 
different types of calcium entry, verapamil blocks the 
prejunctional α2 receptors, which leads to an increase in 
NA release 
18
. Verapamil may have direct catecholamine 
releasing effects, as it interacts with catecholamine storage 
vesicles in a way that reduces their ability to take up and 
store catecholamine, and thereby increasing NA release 
from sympathetic nerves 
17
. Verapamil has no effect on 
NA-induced increase in calcium influx, which means that 
there are verapamil sensitive and verapamil-insensitive 
calcium channels 
18
. Verapamil enhances ATP response, 
which is released along with NA from the motor nerves; 
ATP may indeed be a co-transmitter. Many investigators 
suggested that ATP induces NA release from sympathetic 
neurons via its action on a subclass of the nicotinic 
cholinoceptor, because this effect was blocked by nicotinic 
receptor antagonists 
16
. NA produces depolarization by 
decreasing the membrane permeability to K+ ions. It also 
increases calcium influx to the cells via calcium channel-
activated NA receptors and potential-dependent slow 
calcium channels activated by NA-induced membrane 
depolarization 
14
. NA stimulates calcium chloride 




Imipramine can inhibit presynaptic reuptake of the 
biogenic amines, serotonin, and NA to produce an 
antidepressant action 
19
.Imipramine may produce this 
antidepressant action through a GABA–ergic mechanism, 
causing release of catecholamine. Imipramine may 
increase calcium release from intracellular stores by 
increasing NA concentrations through inhibiting its uptake 
by pre-synaptic sites through GABAA receptor activation. 
This may lead to increased calcium influx through voltage 
gated calcium channels, which ultimately depend on the 
chloride transport system or by depolarization due to an 
increase in the external potassium concentrations. It was 
suspected that this might lead to calcium influx through 
voltage activated calcium channels 
20
. However, nifedipine 
does not affect calcium channel mediation of initial 
response to NA. Nifedipine blocks L-type calcium 
channels activation which is due GABAA receptor 
activation-mediated depolarization which may not play a 
role in the antidepressant action. GABAA receptor 
activation increases the release of calcium from the 
internal stores .Imipramine produces an inhibition of the 
peak threshold calcium current, which probably decreases 
the maximum available calcium conductance 
14
. It was 
suggested that imipramine acts by interfering with the 
influx of extracellular calcium, through both the receptor 
operated and voltage-gated calcium channels, but does not 
affect the release of calcium from intracellular storage sites 
16, 17
. 
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In the present study I showed that verapamil has an 
antidepressant-like effect in the rats in the DST model. 
Treatment with verapamil combined with alprazolam or 
imipramine produces an additive antidepressant effect, 
possibly because verapamil has an antidepressant-like 
effect, but the mechanism is not understood yet. Either 
imipramine or nifedipine produced a delay in the onset of 
immobility of 75% and 81%, respectively, compared to the 
control. Combining nifedipine with imipramine led to a 
delay of 73% in the onset of immobility compared to the 
control; which is less than the additive effect. This 
observation could be explained by the fact that nifedipine 
has its own antidepressant action mechanism but also 
blocks the imipramine mechanism that depends on L-type 
calcium channel activation. 
CONCLUSION  
Though there was limitation of the study as because it was 
conducted at only one institution on the limited number of 
animals, but this study showed that nifedipine possesses 
antidepressant properties. Combining nifedipine with 
alprazolam produced an additive antidepressant effect, 
indicating that different mechanisms were involved. 
Though there is need of further study in this field to arrive 
a definitive conclusion. 
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